{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:00:23Z","timestamp":1793754023770,"version":"4.6.1"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["62993"],"award-info":[{"award-number":["62993"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.molimm.2025.11.019","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T22:39:11Z","timestamp":1764628751000},"page":"13-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Innovations, challenges, and gaps in the development of an effective vaccine against Neisseria gonorrhoeae, a narrative review"],"prefix":"10.1016","volume":"189","author":[{"given":"Narjes","family":"Noori Goodarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-5765","authenticated-orcid":false,"given":"Mohammad Reza","family":"Pourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.11.019_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/infdis\/jiae383","article-title":"Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and meta-analysis","volume":"231","author":"Abara","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib2","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.42981","article-title":"Epidemiological trends and factors associated with the morbidity rate of gonorrhea: a CDC-WONDER database analysis","author":"Akinboro","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.molimm.2025.11.019_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00035-22","article-title":"Variable expression of Opa proteins by Neisseria gonorrhoeae influences bacterial association and phagocytic killing by human neutrophils","volume":"204","author":"Alcott","year":"2022","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2025.11.019_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00331-18","article-title":"Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and generation of murine antibodies with bactericidal Activity against Gonococci","volume":"3","author":"Almonacid-Mendoza","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.molimm.2025.11.019_bib5","first-page":"3","article-title":"Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci","author":"Almonacid-Mendoza","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.molimm.2025.11.019_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.epidem.2024.100785","article-title":"Dynamics of Neisseria gonorrhoeae transmission among female sex workers and clients: a mathematical modeling study","volume":"48","author":"Ayoub","year":"2024","journal-title":"Epidemics"},{"key":"10.1016\/j.molimm.2025.11.019_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00977-20","article-title":"Comprehensive bioinformatic assessments of the variability of Neisseria gonorrhoeae Vaccine candidates","volume":"6","author":"Baarda","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.molimm.2025.11.019_bib8","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/cid\/ciac043","volume":"74","author":"Barbee","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1248613","article-title":"Immune responses to Neisseria gonorrhoeae and implications for vaccine development","volume":"14","author":"Belcher","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/IAI.67.1.455-459.1999","article-title":"Identification and functional characterization of the Neisseria gonorrhoeae lbpB gene product","volume":"67","author":"Biswas","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/iai.54.3.710-713.1986","article-title":"Human immune response to iron-repressible outer membrane proteins of Neisseria meningitidis","volume":"54","author":"Black","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib12","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1128\/IAI.73.4.2222-2231.2005","article-title":"Function of neisserial outer membrane phospholipase a in autolysis and assessment of its vaccine potential","volume":"73","author":"Bos","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","article-title":"Efficacy trial of a parenteral gonococcal pilus vaccine in men","volume":"9","author":"Boslego","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib14","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","article-title":"Prevention of Neisseria gonorrhoeae With Meningococcal B vaccine: a matched cohort study in Southern California","volume":"76","author":"Bruxvoort","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib15","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.01338-10","article-title":"Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci","volume":"79","author":"Callaghan","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-2958.2000.01873.x","article-title":"Phase variation of the gonococcal siderophore receptor FetA","volume":"36","author":"Carson","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib17","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1128\/IAI.00762-15","article-title":"Beyond the crystal structure: insight into the function and vaccine potential of TbpA expressed by Neisseria gonorrhoeae","volume":"83","author":"Cash","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/mpat.1993.1056","article-title":"Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic","volume":"15","author":"Chamberlain","year":"1993","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.molimm.2025.11.019_bib19","first-page":"64","article-title":"Meningococcal quinolone resistance originated from several commensal <i>Neisseria<\/I> species","author":"Chen","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2025.11.019_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008108","article-title":"Functional characterization of antibodies against neisseria gonorrhoeae opacity protein loops","volume":"4","author":"Cole","year":"2009","journal-title":"PLOS ONE"},{"key":"10.1016\/j.molimm.2025.11.019_bib21","article-title":"Policy, practice, and prediction: model-based approaches to evaluating N. Gonorrhoeae antibiotic susceptibility test uptake in Australia","volume":"24","author":"Cong","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.1998.00710.x","article-title":"The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers","volume":"27","author":"Cornelissen","year":"1998","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib23","article-title":"Neisseria gonorrhoeae induces local secretion of IL-10 at the human cervix to promote colonization","volume":"135","author":"Dai","year":"2024","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2025.11.019_bib24","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1099\/00221287-143-7-2127","article-title":"Involvement of the gonococcal MtrE protein in the resistance of Neisseria gonorrhoeae to toxic hydrophobic agents","volume":"143","author":"Delahay","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.molimm.2025.11.019_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijpharm.2013.06.010","article-title":"Long term stability of lyophilized plasmid DNA pDERMATT","volume":"453","author":"van der Heijden","year":"2013","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.molimm.2025.11.019_bib26","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1016\/j.vaccine.2021.05.098","article-title":"Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models","volume":"39","author":"Dey","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib27","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fbrio.2023.1240807","article-title":"An immunoproteomics study of antisera from patients with gonorrhea identifies novel Neisseria gonorrhoeae proteins","volume":"2","author":"Dijokaite-Guraliuc","year":"2023","journal-title":"Front. Bacteriol."},{"key":"10.1016\/j.molimm.2025.11.019_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/antibiotics7030059","article-title":"The growing threat of Gonococcal blindness","volume":"7","author":"Dolange","year":"2018","journal-title":"Antibiotics"},{"key":"10.1016\/j.molimm.2025.11.019_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12879-022-07544-7","article-title":"Increasing incidence rates of sexually transmitted infections from 2010 to 2019: an analysis of temporal trends by geographical regions and age groups from the 2019 Global Burden of Disease Study","volume":"22","author":"Du","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QCO.0000000000000450","article-title":"Neisseria Gonorrhoeae vaccine development: hope on the horizon?","volume":"31","author":"Edwards","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567116","article-title":"Artificial intelligence in vaccine research and development: an umbrella review","volume":"16","author":"El Arab","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038199","article-title":"Global perspectives on the burden of sexually transmitted diseases: a narrative review","volume":"103","author":"Elendu","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.molimm.2025.11.019_bib33","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3389\/fimmu.2018.03044","article-title":"Macrophage\u2013Neisseria gonorrhoeae interactions: a better understanding of pathogen mechanisms of immunomodulation","volume":"9","author":"Escobar","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.idc.2023.02.004","article-title":"Challenges in managing Gonorrhea and new advances in prevention","volume":"37","author":"Ewers","year":"2023","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.molimm.2025.11.019_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fimmu.2019.00247","article-title":"Utility of hybrid transferrin binding protein antigens for protection against pathogenic Neisseria species","volume":"10","author":"Fegan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-024-01054-0","article-title":"Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae","volume":"10","author":"Fegan","year":"2025","journal-title":"npj Vaccin."},{"key":"10.1016\/j.molimm.2025.11.019_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/mi.2009.139","article-title":"Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection","volume":"3","author":"Feinen","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/pathogens12060782","article-title":"Vertebrate and invertebrate animal and new in vitro models for studying Neisseria biology","volume":"12","author":"Girgis","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.molimm.2025.11.019_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35750-4","article-title":"Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the oxford nanopore MinION sequencer","volume":"8","author":"Golparian","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2025.11.019_bib40","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez, N., Abdellati, S., Manoharan-Basil, S.S., Kenyon, C., 2021. Association Between Quinolone Use in Food Animals and Gonococcal Resistance to Ciprofloxacin: An Ecological Study.","DOI":"10.1101\/2021.06.03.446933"},{"key":"10.1016\/j.molimm.2025.11.019_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00309-23","article-title":"Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine","volume":"91","author":"Gray","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib42","first-page":"e00309","article-title":"Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine","volume":"91","author":"Gray Mary","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib43","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/174.6.1223","article-title":"Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids","volume":"174","author":"Gulati","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003559","article-title":"Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection","volume":"9","author":"Gulati","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2025.11.019_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02552-19","article-title":"Preclinical efficacy of a lipooligosaccharide peptide mimic candidate gonococcal vaccine","volume":"10","author":"Gulati","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.molimm.2025.11.019_bib46","doi-asserted-by":"crossref","first-page":"e02500","DOI":"10.1128\/mbio.02500-23","article-title":"Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence","volume":"14","author":"Gulati","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.molimm.2025.11.019_bib47","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fmicb.2020.01299","article-title":"Intimate relations: molecular and immunologic interactions between neisseria gonorrhoeae and HIV-1","volume":"11","author":"Guvenc","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib48","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.vaccine.2011.12.076","article-title":"Recombinant outer membrane secretin PilQ406\u2013770 as a vaccine candidate for serogroup B Neisseria meningitidis","volume":"30","author":"Haghi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib49","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1097\/OLQ.0000000000001331","article-title":"A critical need for research on gonorrhea vaccine acceptability","volume":"48","author":"Harvey","year":"2020","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib50","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1128\/IAI.66.12.5826-5832.1998","article-title":"Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae","volume":"66","author":"Hedges","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib51","doi-asserted-by":"crossref","unstructured":"Heijne, J.C.M., Xiridou, M., Turner, K., Basten, M., Visser, M., Benthem, Bv, Low, N., 2020. The Impact of Vaccination on <i>Neisseria Gonorrhoeae<\/I> Antimicrobial Resistance and Prevalence in Men Who Have Sex With Men: A Mathematical Modelling Study.","DOI":"10.1101\/2020.09.14.20192062"},{"key":"10.1016\/j.molimm.2025.11.019_bib52","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fcimb.2022.840122","article-title":"Tissue models for neisseria gonorrhoeae research\u2014from 2D to 3D","volume":"12","author":"Heydarian","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib53","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/IAI.00687-07","article-title":"Dynamics of Neisseria gonorrhoeae attachment: microcolony development, cortical plaque formation, and cytoprotection","volume":"75","author":"Higashi","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15698\/mic2016.09.524","article-title":"Gonorrhea - an evolving disease of the new millennium","volume":"3","author":"Hill","year":"2016","journal-title":"Micro Cell"},{"key":"10.1016\/j.molimm.2025.11.019_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00319-18","article-title":"Draft genome sequences of interpatient and intrapatient epidemiologically linked neisseria gonorrhoeae isolates","volume":"6","author":"Hirk","year":"2018","journal-title":"Genome Announc."},{"key":"10.1016\/j.molimm.2025.11.019_bib56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4939-9496-0_25","article-title":"Experimental human infection with neisseria gonorrhoeae","volume":"1997","author":"Hobbs","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molimm.2025.11.019_bib57","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/cid\/ciz899","article-title":"Development of new antimicrobials for urogenital gonorrhea therapy: clinical trial design considerations","volume":"70","author":"Hook","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib58","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/infdis\/jiab581","article-title":"A gonococcal vaccine has the potential to rapidly reduce the incidence of <i>Neisseria Gonorrhoeae<\/I> infection among urban men who have sex with men","volume":"225","author":"Hui","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib59","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.vaccine.2018.05.069","article-title":"Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae","volume":"36","author":"Humbert","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006448","article-title":"Structure of the Neisseria Adhesin Complex Protein (ACP) and its role as a novel lysozyme inhibitor","volume":"13","author":"Humbert","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2025.11.019_bib61","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.10.57","article-title":"DNA vaccines for targeting bacterial infections","volume":"9","author":"Ingolotti","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.molimm.2025.11.019_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126709","article-title":"Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria","volume":"48","author":"Islam","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib63","article-title":"Pharmacodynamic evaluation of Zoliflodacin treatment of Neisseria gonorrhoeae strains with amino acid substitutions in the Zoliflodacin target GyrB using a dynamic hollow fiber infection model","volume":"13","author":"Jacobsson","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molimm.2025.11.019_bib64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fimmu.2019.00137","article-title":"The Neisseria gonorrhoeae methionine sulfoxide reductase (MsrA\/B) Is a surface exposed, immunogenic, vaccine candidate","volume":"10","author":"Jen","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib65","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/IAI.67.11.5699-5708.1999","article-title":"Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice","volume":"67","author":"Jerse","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib66","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/jam.14815","article-title":"Enhancement of immune responses by co-administration of bacterial ghosts-mediated Neisseria gonorrhoeae DNA vaccines","volume":"130","author":"Jiao","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib67","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/IAI.67.6.3009-3013.1999","article-title":"A Neisseria gonorrhoeae immunoglobulin A1 protease mutant is infectious in the human challenge model of urethral infection","volume":"67","author":"Johannsen","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012688","article-title":"Tackling immunosuppression by Neisseria gonorrhoeae to facilitate vaccine design","volume":"20","author":"Jones","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2025.11.019_bib69","doi-asserted-by":"crossref","unstructured":"Jongen, V.W., Maarten, F.SvdL., Elshout, Mvd, Wijstma, E., Coyer, L., Davidovich, U., Vries, H.Jd, Prins, M., Hoornenborg, E., Boyd, A., 2023. Bacterial Sexually Transmitted Infections Are Concentrated in Subpopulations of MSM Using HIV PrEP: An Analysis of Longitudinal Trajectories. Aids.","DOI":"10.1097\/QAD.0000000000003676"},{"key":"10.1016\/j.molimm.2025.11.019_bib70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2025.11.019_bib71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/infdis\/jiv031","article-title":"A thermonuclease of Neisseria gonorrhoeae enhances bacterial escape from killing by neutrophil extracellular traps","volume":"212","author":"Juneau","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib72","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fmolb.2024.1442158","article-title":"Artificial intelligence-driven reverse vaccinology for Neisseria gonorrhoeae vaccine: prioritizing epitope-based candidates","volume":"11","author":"Kant","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.molimm.2025.11.019_bib73","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3201\/eid2407.172104","article-title":"Effects of sexual network connectivity and antimicrobial drug use on antimicrobial resistance In<i>Neisseria Gonorrhoeae<\/I>.","volume":"24","author":"Kenyon","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1071\/SH19061","article-title":"Epidemiology of Gonorrhoea: a global perspective","volume":"16","author":"Kirkcaldy","year":"2019","journal-title":"Sex. Health"},{"key":"10.1016\/j.molimm.2025.11.019_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202437","article-title":"Phage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates","volume":"13","author":"K\u0142y\u017c","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.11.019_bib76","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2958.1999.01530.x","article-title":"The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids","volume":"33","author":"Lee","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib77","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4049\/jimmunol.180.10.6827","article-title":"CEACAM1 dynamics during neisseria gonorrhoeae suppression of CD4+ T lymphocyte activation","volume":"180","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.molimm.2025.11.019_bib79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","article-title":"Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications","volume":"22","author":"Leong","year":"2025","journal-title":"Virol. J."},{"key":"10.1016\/j.molimm.2025.11.019_bib80","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/CVI.05245-11","article-title":"Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice","volume":"18","author":"Li","year":"2011","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib81","article-title":"Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.11.019_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/vaccines13030248","article-title":"Epitope-Based Vaccines: The Next Generation of Promising Vaccines Against Bacterial Infection","volume":"13","author":"Li","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib83","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mi.2012.12","article-title":"Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-\u03b2-dependent mechanisms","volume":"5","author":"Liu","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib84","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mi.2017.11","article-title":"Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model","volume":"10","author":"Liu","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1473193","article-title":"Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against Neisseria gonorrhoeae","volume":"15","author":"Lu","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib86","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2023.01.053","article-title":"Vaccine value profile for Neisseria gonorrhoeae","volume":"42","author":"Lyu","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.793612","article-title":"Horizontal gene transfer of fluoroquinolone resistance-conferring genes from commensal neisseria to neisseria gonorrhoeae: a global phylogenetic analysis of 20,047 isolates","volume":"13","author":"Manoharan-Basil","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01668-19","article-title":"Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine","volume":"10","author":"Marjuki","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.molimm.2025.11.019_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10020309","article-title":"An observational study to assess the effectiveness of 4CMenB against Meningococcal disease and carriage and gonorrhea in adolescents in the northern territory, Australia-study protocol","volume":"10","author":"Marshall","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00245-23","article-title":"Development of a Tag\/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme","volume":"91","author":"Martinez","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib91","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fcimb.2022.881392","article-title":"Recent progress towards a gonococcal vaccine","volume":"12","author":"Maurakis","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib92","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"Mmwr. Recomm. Rep."},{"key":"10.1016\/j.molimm.2025.11.019_bib93","series-title":"Evaxion partners with Afrigen Biologics to develop mRNA gonorrhea vaccine","author":"Medicine","year":"2025"},{"key":"10.1016\/j.molimm.2025.11.019_bib94","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/iai.35.3.915-920.1982","article-title":"Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin","volume":"35","author":"Mickelsen","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib95","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a;2 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib96","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.chom.2020.03.010","article-title":"Neisseria gonorrhoeae Blocks Epithelial Exfoliation by Nitric-Oxide-Mediated Metabolic Cross Talk to Promote Colonization in Mice","volume":"27","author":"Muenzner","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molimm.2025.11.019_bib97","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1590\/S0100-879X2012007500142","article-title":"Recombinant vaccines and the development of new vaccine strategies","volume":"45","author":"Nascimento","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.molimm.2025.11.019_bib98","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vaccine.2005.07.065","article-title":"Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function","volume":"24","author":"Ngampasutadol","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/infdis\/jiae123","article-title":"Cost-effectiveness of 4CMenB vaccination against Gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection","volume":"231","author":"Nikitin","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2023.105449","article-title":"Reverse vaccinology approaches to introduce promising immunogenic and drug targets against antibiotic-resistant Neisseria gonorrhoeae: Thinking outside the box in current prevention and treatment","volume":"112","author":"Noori Goodarzi","year":"2023","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.molimm.2025.11.019_bib101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-025-06256-1","article-title":"Immunogenic evaluation of LptD\u2009+\u2009LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae","volume":"23","author":"Noori Goodarzi","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2025.11.019_bib102","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-025-06256-1","article-title":"Immunogenic evaluation of LptD\u2009+\u2009LtgC as a bivalent vaccine candidate against Neisseria gonorrhoeae","volume":"23","author":"Noori Goodarzi","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molimm.2025.11.019_bib103","doi-asserted-by":"crossref","DOI":"10.1097\/MS9.0000000000001854","article-title":"The burden, elimination efforts and implication for health policy of gonorrhoea in Africa: an editorial","author":"Oduoye","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.molimm.2025.11.019_bib104","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1093\/bioinformatics\/btaa119","article-title":"Vaxign-ML: supervised machine learning reverse vaccinology model for improved prediction of bacterial protective antigens","volume":"36","author":"Ong","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molimm.2025.11.019_bib105","series-title":"WHO preferred product characteristics for gonococcal vaccines, WHO preferred product characteristics for gonococcal vaccines","author":"Organization","year":"2021"},{"key":"10.1016\/j.molimm.2025.11.019_bib106","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030","author":"Organization","year":"2022"},{"key":"10.1016\/j.molimm.2025.11.019_bib107","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB\u2122: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/IAI.00711-09","article-title":"Mouse Strain-Dependent Differences in Susceptibility to Neisseria gonorrhoeae Infection and Induction of Innate Immune Responses","volume":"78","author":"Packiam","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib109","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.vaccine.2024.03.068","article-title":"Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development","volume":"42","author":"Padeniya","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA Vaccines: History, Molecular Mechanisms and Future Perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molimm.2025.11.019_bib111","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.micinf.2011.01.018","article-title":"Attenuated virulence of min operon mutants of Neisseria gonorrhoeae and their interactions with human urethral epithelial cells","volume":"13","author":"Parti","year":"2011","journal-title":"Microbes Infect."},{"key":"10.1016\/j.molimm.2025.11.019_bib112","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2025.11.019_bib113","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.vaccine.2006.02.003","article-title":"Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB","volume":"24","author":"Pettersson","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/srep22549","article-title":"Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage \u03a66 Induces Bactericidal Antibodies Against N. gonorrhoeae","volume":"6","author":"Piekarowicz","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2025.11.019_bib115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12934-022-01929-8","article-title":"Recombinant vaccines in 2022: a perspective from the cell factory","volume":"21","author":"de Pinho Favaro","year":"2022","journal-title":"Micro Cell Fact."},{"key":"10.1016\/j.molimm.2025.11.019_bib116","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib117","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1172\/JCI117159","article-title":"Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis","volume":"93","author":"Plummer","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molimm.2025.11.019_bib118","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.0.CO;2-W","article-title":"Chemical stability of nucleic acid-derived drugs","volume":"89","author":"Pogocki","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.molimm.2025.11.019_bib119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2021.01.001","article-title":"Recombinant protein vaccines, a proven approach against coronavirus pandemics","volume":"170","author":"Pollet","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molimm.2025.11.019_bib120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/IAI.72.1.277-283.2004","article-title":"Immunogenicity of Gonococcal Transferrin Binding Proteins during Natural Infections","volume":"72","author":"Price","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib121","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","article-title":"Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice","volume":"73","author":"Price","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib122","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1016\/j.vaccine.2007.07.038","article-title":"Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice","volume":"25","author":"Price","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib123","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","article-title":"Neisseria gonorrhoeae host adaptation and pathogenesis","volume":"16","author":"Quillin","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib124","first-page":"47","article-title":"Adjuvants Derived From <i>Neisseria Meningitidis<\/I> Serogroup B Induce a Cross Reactive Response Against <i>Neisseria Gonorrhoeae<\/I> In Mice. Open","volume":"10","author":"Reyes","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu Rev. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib126","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3390\/vaccines11121846","article-title":"In Vitro Pre-clinical evaluation of a gonococcal trivalent candidate vaccine identified by transcriptomics","volume":"11","author":"Roe","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib127","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae289","article-title":"Urgent need to understand and prevent Gonococcal Infection: from the laboratory to real-world context","author":"Ruiz Garc\u00eda","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1574-6976.2010.00260.x","article-title":"Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria","volume":"35","author":"Sadarangani","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.molimm.2025.11.019_bib129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2019.00073","article-title":"The pathogenic neisseria use a streamlined set of peptidoglycan degradation proteins for peptidoglycan remodeling, recycling, and toxic fragment release","volume":"10","author":"Schaub","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib130","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/OLQ.0000000000001545","article-title":"Strengthening the US response to resistant gonorrhea: an overview of a multisite program to enhance local response capacity for antibiotic-resistant neisseria gonorrhoeae","volume":"48","author":"Schlanger","year":"2021","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12091000","article-title":"Stability preparedness: the Not-So-Cold case for innovations in vaccine stability modelling and product release","volume":"12","author":"Schnetzinger","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib132","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00898-16","article-title":"MetQ of Neisseria gonorrhoeae Is a surface-expressed antigen that elicits bactericidal and functional blocking antibodies","volume":"85","author":"Semchenko","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib133","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The Serogroup B meningococcal vaccine bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib134","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/infdis\/jiz628","article-title":"Role of the gonococcal neisserial heparin binding antigen in microcolony formation, and serum resistance and adherence to epithelial cells","volume":"221","author":"Semchenko","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1071\/MA20055","article-title":"Gonorrhoea: past, present and future","volume":"41","author":"Semchenko","year":"2020","journal-title":"Microbiol. Aust."},{"key":"10.1016\/j.molimm.2025.11.019_bib136","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/vaccines8020219","article-title":"The Neisseria gonorrhoeae Vaccine candidate NHBA elicits antibodies that are bactericidal, opsonophagocytic and that reduce gonococcal adherence to epithelial cells","volume":"8","author":"Semchenko","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib137","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1365-2958.2007.05745.x","article-title":"Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization","volume":"64","author":"Serino","year":"2007","journal-title":"Mol. Microbiol."},{"issue":"2","key":"10.1016\/j.molimm.2025.11.019_bib138","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4808","article-title":"VirulentPred 2.0: An improved method for prediction of virulent proteins in bacterial pathogens","volume":"32","author":"Sharma","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.molimm.2025.11.019_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182555","article-title":"Refinement of immunizing antigens to produce functional blocking antibodies against the AniA nitrite reductase of Neisseria gonorrhoeae","volume":"12","author":"Shewell","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.11.019_bib141","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/infdis\/145.3.300","article-title":"Gonococcal Pili: safety and immunogenicity in humans and antibody function in vitro","volume":"145","author":"Siegel","year":"1982","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib142","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2020.10.077","article-title":"A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection","volume":"38","author":"Sikora","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib143","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2249124","article-title":"Th1-polarized MtrE-based gonococcal vaccines display prophylactic and therapeutic efficacy","volume":"12","author":"Song","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.molimm.2025.11.019_bib144","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41541-025-01190-1","article-title":"A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice","volume":"10","author":"Spinsanti","year":"2025","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.molimm.2025.11.019_bib145","first-page":"167","article-title":"Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A","volume":"33","author":"Starnino","year":"2010","journal-title":"N. Microbiol"},{"key":"10.1016\/j.molimm.2025.11.019_bib146","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03932-2","article-title":"Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9","volume":"11","author":"Tarrahimofrad","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2025.11.019_bib147","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1172\/JCI110343","article-title":"Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment","volume":"68","author":"Tramont","year":"1981","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molimm.2025.11.019_bib148","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.molimm.2025.11.019_bib149","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462420948739","article-title":"Background Review for the \u20182020 European Guideline for the Diagnosis and Treatment of Gonorrhoea in Adults\u2019","volume":"32","author":"Unemo","year":"2020","journal-title":"Int. J. STD Aids"},{"key":"10.1016\/j.molimm.2025.11.019_bib150","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/jac\/dkae176","article-title":"The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization","volume":"79","author":"Unemo","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molimm.2025.11.019_bib151","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/JB.184.20.5619-5624.2002","article-title":"Overexpression of the MtrC-MtrD-MtrE Efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in neisseria gonorrhoeae","volume":"184","author":"Veal","year":"2002","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2025.11.019_bib152","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1016\/j.vaccine.2018.02.081","article-title":"Biological feasibility and importance of a gonorrhea vaccine for global public health","volume":"37","author":"Vincent","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1119834","article-title":"Mechanisms of host manipulation by Neisseria gonorrhoeae","volume":"14","author":"Walker","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2025.11.019_bib154","first-page":"109","article-title":"Experimental Urethral Infection with Neisseria gonorrhoeae","volume":"445","author":"Waltmann","year":"2024","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib155","doi-asserted-by":"crossref","DOI":"10.1071\/MA24034","article-title":"The future role of vaccination in prevention of Neisseria gonorrhoeae","author":"Wang","year":"2024","journal-title":"Microbiol. Aust."},{"key":"10.1016\/j.molimm.2025.11.019_bib156","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jinf.2018.06.001","article-title":"Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies","volume":"77","author":"Wang","year":"2018","journal-title":"J. Infect."},{"key":"10.1016\/j.molimm.2025.11.019_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011055","article-title":"Neisseria gonorrhoeae co-opts C4b-binding protein to enhance complement-independent survival from neutrophils","volume":"19","author":"Werner","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molimm.2025.11.019_bib158","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/cid\/ciz1241","article-title":"Assessment of the potential of vaccination to combat antibiotic resistance in gonorrhea: a modeling analysis to determine preferred product characteristics","volume":"71","author":"Whittles","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib159","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S1473-3099(21)00744-1","article-title":"Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis","volume":"22","author":"Whittles","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib160","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/infdis\/jiaf029","article-title":"Rationale and ethical assessment of an oropharyngeal Gonorrhea controlled human infection model","volume":"231","author":"Williams","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2025.11.019_bib161","article-title":"Characterization of protective immune responses against Neisseria gonorrhoeae induced by intranasal immunization with adhesion and penetration protein","volume":"10","author":"Xia","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.molimm.2025.11.019_bib162","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jri.2007.04.008","article-title":"Expression of Toll-like receptors in murine vaginal epithelium is affected by the estrous cycle and stromal cells","volume":"75","author":"Yao","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.molimm.2025.11.019_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12080863","article-title":"Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines","volume":"12","author":"Yount","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib164","article-title":"CELLO2GO: a web server for protein subCELlular LOcalization prediction with functional gene ontology annotation","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2025.11.019_bib165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","article-title":"Mucosal immune response in biology, disease prevention and treatment","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molimm.2025.11.019_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7040153","article-title":"Integrated bioinformatic analyses and immune characterization of new Neisseria gonorrhoeae vaccine antigens expressed during natural mucosal infection","volume":"7","author":"Zhu","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2025.11.019_bib167","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.vaccine.2003.08.036","article-title":"DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment","volume":"22","author":"Zhu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2025.11.019_bib168","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1128\/IAI.73.11.7558-7568.2005","article-title":"Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or venezuelan equine encephalitis virus replicon particles","volume":"73","author":"Zhu","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2025.11.019_bib169","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven antigen discovery for development of vaccines against gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol. Cell. Proteom."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:53:10Z","timestamp":1777492390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":169,"alternative-id":["S0161589025002731"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.11.019","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovations, challenges, and gaps in the development of an effective vaccine against Neisseria gonorrhoeae, a narrative review","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}